Compare ALEMBIC PHARMA with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA TTK HEALTHCARE ALEMBIC PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 16.1 19.3 83.5% View Chart
P/BV x 3.7 1.5 240.1% View Chart
Dividend Yield % 1.0 1.0 102.8%  

Financials

 ALEMBIC PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
TTK HEALTHCARE
Mar-19
ALEMBIC PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs6641,215 54.7%   
Low Rs412610 67.6%   
Sales per share (Unadj.) Rs208.7444.4 47.0%  
Earnings per share (Unadj.) Rs31.017.2 179.7%  
Cash flow per share (Unadj.) Rs37.127.6 134.3%  
Dividends per share (Unadj.) Rs5.505.00 110.0%  
Dividend yield (eoy) %1.00.5 186.5%  
Book value per share (Unadj.) Rs144.2177.9 81.0%  
Shares outstanding (eoy) m188.5214.13 1,334.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.62.1 125.6%   
Avg P/E ratio x17.452.9 32.8%  
P/CF ratio (eoy) x14.533.0 43.9%  
Price / Book Value ratio x3.75.1 72.8%  
Dividend payout %17.729.0 61.2%   
Avg Mkt Cap Rs m101,46112,894 786.9%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m7,4671,307 571.3%   
Avg. sales/employee Rs ThNM2,715.7-  
Avg. wages/employee Rs ThNM565.3-  
Avg. net profit/employee Rs ThNM105.4-  
INCOME DATA
Net Sales Rs m39,3476,279 626.7%  
Other income Rs m9478 121.0%   
Total revenues Rs m39,4416,356 620.5%   
Gross profit Rs m8,736496 1,762.7%  
Depreciation Rs m1,152147 785.5%   
Interest Rs m18434 544.7%   
Profit before tax Rs m7,493393 1,908.6%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568149 1,052.7%   
Profit after tax Rs m5,844244 2,397.9%  
Gross profit margin %22.27.9 281.3%  
Effective tax rate %20.937.9 55.2%   
Net profit margin %14.93.9 382.6%  
BALANCE SHEET DATA
Current assets Rs m19,5772,717 720.5%   
Current liabilities Rs m14,8961,571 948.3%   
Net working cap to sales %11.918.3 65.2%  
Current ratio x1.31.7 76.0%  
Inventory Days Days9032 279.1%  
Debtors Days Days4547 97.2%  
Net fixed assets Rs m27,097991 2,734.3%   
Share capital Rs m377141 266.8%   
"Free" reserves Rs m26,8112,373 1,129.8%   
Net worth Rs m27,1882,514 1,081.3%   
Long term debt Rs m4,9933 146,852.9%   
Total assets Rs m47,7784,158 1,149.0%  
Interest coverage x41.712.6 330.6%   
Debt to equity ratio x0.20 13,580.6%  
Sales to assets ratio x0.81.5 54.5%   
Return on assets %12.66.7 189.0%  
Return on equity %21.59.7 221.8%  
Return on capital %23.616.9 139.4%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m19,453225 8,638.0%   
Fx outflow Rs m6,06571 8,528.8%   
Net fx Rs m13,388154 8,688.4%   
CASH FLOW
From Operations Rs m8,120173 4,690.7%  
From Investments Rs m-7,55697 -7,830.1%  
From Financial Activity Rs m590-307 -192.1%  
Net Cashflow Rs m1,153-38 -3,059.2%  

Share Holding

Indian Promoters % 74.1 65.4 113.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 3.7 78.4%  
FIIs % 9.1 5.2 175.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 25.8 53.9%  
Shareholders   49,328 12,723 387.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON   PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Rally; Sensex Zooms 1,250 Points(12:30 pm)

Share markets in India are presently trading on a strong note, cheering the government's move to cut corporate tax rates to boost economic growth.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Sep 23, 2019 12:33 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS